Cracking the Epigenetic Code
News Oct 25, 2012
Lead researcher, Dr David Tremethick from The John Curtin School of Medical Research, said developing a better understanding of these epigenetic processes has significant potential implications for human health, in particular the treatment and prevention of diseases such as cancer.
The findings have been published in a new paper on the Nature Structural & Molecular Biology website today.
Epigenetics is the new frontier of genetic science. Epigenetic mechanisms go beyond DNA-stored information to provide an additional layer of information that controls when and where genes are expressed. It determines which fraction of the 20,000 genes that make up the human genome come into play to ensure the right genes are expressed in the correct cell type. This epigenetic information must be passed down through generations or ‘inherited’ in order for cells to function properly throughout our lives.
“We know cells are regenerating all the time and that epigenetic information must therefore be continually restored, the question is how this actually happens,” Dr Tremethick said.
“Our study focused on this important unanswered question by investigating how epigenetic information is restored following the cellular division of stem cells, which is essential for their renewal.
“Using mouse stem cells as a model system we found that the inheritance of epigenetic information, how information is passed along, was much more dynamic and unstable than we expected.
“From a health perspective, this has both positive and negative consequences. On the one hand, this instability opens up the possibility of information being corrupted as it is passed from cell to cell, causing disease. On the other, it points to the potential of one day being able to intervene in the process to correct corrupted information or stop it being passed on to another generation.
“The next step is to understand how this epigenomic information is naturally altered to allow the proper transition from a stem cell to a lineage-committed cell that occurs during human embryo development. This, in turn, will allow a better understanding of how this inheritance process goes wrong in diseases such as cancer.”
Dr Tremethick said the latest breakthroughs in technology in sequencing DNA has allowed a revolution in the field of epigenetics, in which the John Curtin School of Medical Research has become a major international player.
“We look forward to achieving more positive results from our research program and contributing to global advances in this cutting-edge field of epigenetics,” he said.
Mechanism Controlling Multiple Sclerosis Risk IdentifiedNews
Researchers at Karolinska Institutet have now discovered a new mechanism of a major risk gene for multiple sclerosis (MS) that triggers disease through so-called epigenetic regulation. They also found a protective genetic variant that reduces the risk for MS through the same mechanism.
Synthetic DNA Shuffling Enzyme Outpaces Natural CounterpartNews
A new synthetic enzyme, crafted from DNA rather than protein, flips lipid molecules within the cell membrane, triggering a signal pathway that could be harnessed to induce cell death in cancer cells. Researchers say their lipid-scrambling DNA enzyme is the first in its class to outperform naturally occurring enzymes – and does so by three orders of magnitudeREAD MORE
Antarctic Worm and Machine Learning Help Identify Cerebral Palsy EarlierNews
A research team has released a study in the peer-reviewed journal BMC Bioinformatics showing that DNA methylation patterns in circulating blood cells can be used to help identify spastic cerebral palsy (CP) patients. The technique which makes use of machine learning, data science and even analysis of Antarctic worms, raises hopes for earlier targeted CP therapies.